April 19-23, 2020 • Sheraton Phoenix Downtown • Phoenix, AZ
![AAEM20](/_include/meetings/2020/images/main-pic.jpg)
![AAEM20](/_include/meetings/2020/images/main-pic-title.jpg)
Jointly provided by the American Academy of Addiction Psychiatry, a DATA 2000 sponsoring organization and Providers Clinical Support System
Emergency physicians are uniquely positioned to impact the opioid epidemic because the emergency department is where these patients come for care. This course will provide the tools to turn lives around with best practice addiction treatments and satisfies eight hours of training required by federal law to prescribe buprenorphine, the most effective treatment for opioid use disorder.
← Back to all pre-conference courses
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Emergency Medicine (AAEM) and the American Academy of Addiction Psychiatry (AAAP). The American Academy of Emergency Medicine (AAEM) is accredited by the ACCME to provide continuing medical education for physicians.
The American Academy of Emergency Medicine designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Method of physician participation in the learning process: Credit will only be awarded for completing all of the training. To be awarded a maximum of 8.25 AMA PRA Category 1 Credits™ and a Buprenorphine Training Completion Certificate you must complete all 8 hours of the course. Those completing the course will be able to complete the waiver application online.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government
This course will provide the participant (with a focus on emergency providers) with a knowledge of:
Please confirm your eligibility prior to registering: To apply for a waiver you must have a valid medical license and an active DEA number. Residents may take the course and apply for their waiver when they receive their DEA license. Medical students are also welcome to take the course.
Sunday, April 19, 2020
8:00am-9:00am |
Welcome, Introductions, Plan for the Day Module 1: Course Overview Module 2: Neurobiology, OUD as a Medical Disease |
9:00am-9:30am |
Case #1: Addicted School Teacher (Clinic Case) Case #2: A Sick Elderly Patient (ED Case) |
9:30am-9:55am |
Module 3: Pharmacology of Methadone and Naltrexone |
9:55am-10:10am |
Break |
10:10am-10:35am |
Module 4: Pharmacology of Buprenorphine |
10:35am-10:50am |
Case #3: Treatment Goals (Clinic Case) |
10:50am-11:40am |
Module 5: Opioid Withdrawal Management Module 6: Initiation of MAT with Buprenorphine in the ED |
11:40am-12:00pm |
Case #4: Methadone and Withdrawal (ED Case) |
12:00pm-12:30pm |
Lunch Break (Box lunch included) |
12:30pm-12:50pm |
Case #5: Precipitated Withdrawal Management (ED Case) |
12:50pm-1:40pm |
Module 7: Urine Drug Testing (UDS) and Other Laboratory Tests Module 8: Successful Systems Building: Bridging Patients from the ED |
1:40pm-2:10pm |
Case #6: Overdose Case (ED Case) Case #7: Opioid Withdrawal & Pain Management (ED Case) |
2:10pm-2:40pm |
Module 9: Special Populations |
2:40pm-2:55pm |
Break |
2:55pm-3:20pm |
Module 10: Pain Management for Patients with OUD |
3:20pm-3:50pm |
Case #8: Pain Management (ED Case) Case #9: Addiction and Depression (Clinic Case) |
3:50pm-4:40pm |
Module 11: Counseling, Motivational Interviewing Module 12: Legal & Regulatory Considerations |
4:40pm-5:00pm |
Completion of DEA Waiver; Course Evaluations |
*Schedule subject to change.
Eric Ketcham, MD MBA FAAEM FACEP FASAM FACHE
Department of Emergency Medicine & Department of Behavioral Health (Addiction Medicine Consult Service), Presbyterian Health System, Santa Fe & Espanola, NM; Medical Director, New Mexico Treatment Services (Opioid Addiction Treatment Program), Farmington, NM
Reuben Strayer, MD FRCP FAAEM
Associate Medical Director, Department of Emergency Medicine, Maimonides Medical Center, Brooklyn, NY